Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Hepatology International|November 11, 2020
APASL practical recommendations for the management of hepatocellular carcinoma in the era of COVID-19Shuichiro Shiina, Rino A Gani, Osamu Yokosuka, et al.
Liver Cancer|February 2, 2026
Utility of Biomarker Panels in the Surveillance and Monitoring of Hepatocellular Carcinoma: Consensus Statements from an International Delphi PanelAmit G Singal, Hidenori Toyoda, Tawesak Tanwandee, et al.
Clinical and Molecular Hepatology|March 4, 2025
Liver Disease Trends in the Asia-Pacific Region for the Next 50 YearsShuichiro Shiina, Javkhlan Maikhuu, Qing Deng, et al.
American Journal of Human Genetics|April 30, 2019
Somatic PDGFRB Activating Variants in Fusiform Cerebral AneurysmsYigit Karasozen, Joshua W Osbun, Carolina Angelica Parada, et al.
Orphanet Journal of Rare Diseases|August 10, 2011
Understanding the impact of 1q21.1 copy number variantChansonette Harvard, Emma Strong, Eloi Mercier, et al.
JCI Insight|October 5, 2016
Identifying candidate genes for 2p15p16.1 microdeletion syndrome using clinical, genomic, and functional analysisHani Bagheri, Chansonette Badduke, Ying Qiao, et al.
American Journal of Human Genetics|July 2, 2013
Mutations in PIK3R1 cause SHORT syndromeDavid A Dyment, Amanda C Smith, Diana Alcantara, et al.
Hepatology International|June 17, 2017
Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 updateMasao Omata, Ann-Lii Cheng, Norihiro Kokudo, et al.
Oncotarget|February 7, 2023
The "extreme phenotype approach" applied to male breast cancer allows the identification of rare variants of ATR as potential breast cancer susceptibility allelesMartin Chevarin, Diana Alcantara, Juliette Albuisson, et al.
American Journal of Human Genetics|March 5, 2016
Mosaic Activating Mutations in FGFR1 Cause Encephalocraniocutaneous LipomatosisJames T Bennett, Tiong Yang Tan, Diana Alcantara, et al.
Pageof 4